Safety and Efficacy of Mosunetuzumab in Elderly Patients With DLBCL
October 26th 2023Adam J. Olszewski, MD, discusses findings from a phase 1b/2 study which evaluated treatment with mosunetuzumab for the treatment of elderly/unfit patients who were previously untreated for their diffuse large B-cell lymphoma.